[PDF] Top 20 HER 2 therapy HER 2/neu diagnostics in breast cancer

HER 2 therapy HER 2/neu diagnostics in breast cancer

... serum HER-2/ neu test with a standardized cutpoint of 15 ng/ml, many reports used different research assays with various, uncharacterized antibody specificities, calibrators, and cutoff values to ... See full document

11

Cancer biomarker HER-2/neu in breast cancer in Indian women

... neu protein, such as the tyrosine kinase inhibitor lapatinib, which appears to have clinical activity after failure of trastuzumab therapy. 24 Tumors, including metastatic lesions, shed large numbers of ... See full document

6

Patterns of HER-2/neu Amplification and Overexpression in Primary and Metastatic Breast Cancer

... The HER-2/neu (also known as ERBB2) proto-oncogene, which encodes a trans- membrane growth factor receptor with tyrosine kinase activity, has become an important subject for human cancer re- ... See full document

6

Triple-negative (ER, PgR, HER-2/neu) breast cancer in Indian women

... TN breast cancer has aggressive clinical and pathologic features, including onset at a young age, advanced stage at diagnosis, high histopathologic and nuclear grade, high mitotic index, higher frequency of ... See full document

11

Tumor escape and progression of HER 2/neu negative breast cancer under immune pressure

... If HER-2/neu-specific IFN-g producing T cells are involved in HER-2/neu loss and tumor recurrence, we might be able to detect such immune responses in patients with ... See full document

5

Correlation of ER, PR and Her-2/Neu with Histological Variants of Breast Carcinoma.

... studied HER-2/neu oncogene overexpression which was much higher among Indian breast cancer patients ...(Tab.6). HER-2/neu overexpression was in ... See full document

69

Interlaboratory concordance in HER-2 positive breast cancer

... measures Her-2 gene amplification, has been added to the armamentarium of tests that can be used to identify patients with Her-2 positive tumor for trastuzumab ...of Her-2 ... See full document

7

The impact of nottinghem prognostic index (NPI) on the occurrence of relapses in her 2 / NEU positive breast cancer

... of breast, along with the stage of the disease, and the parameters involved in determining the degree of histological differentiation of primary breast cancer are relevant factors that reflect the ... See full document

5

Prevalence of HER-2/ neu receptor amplification and its effects over prognosis of the patients with breast cancer

... studies HER-2/neu protein expression associated with breast cancers has been ...6-7 HER-2 /neu gene expression has generally not been specifically implicated in ... See full document

5

Cytoplasmic p21WAF1/CIP1 expression is correlated with HER 2/ neu in breast cancer and is an independent predictor of prognosis

... to HER-2 and sub- cellular localisation of p21 WAF1/CIP1 , with future possibilities that immunodetection of phosphorylated p21 WAF1/CIP1 may imply activation of this ...of HER-2-expressing ... See full document

8

Evaluation of HER-2/neu status in Gastric Carcinoma

... of cancer in both males and females. It is also listed among the top cancer related ...gastric cancer, none has shown to improve the survival ...targeted therapy has recently come into play ... See full document

106

Cytotoxic T-cell precursor frequencies to HER-2 ( ) in patients with HER-2/neu-positive epithelial tumours

... 1 Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 171 Alexandras Avenue, 115 22 Athens, Greece; 2 Breast Cancer Clinic, Saint Savas Cancer Hospital, 171 ... See full document

HER-2/neu overexpression correlates with increased expression of VEGF in primary breast carcinoma

... both HER-2/neu and VEGF for treatment of breast cancers that exhibit HER-2/neu ...between HER-2/neu and VEGF in breast cancer and its ... See full document

8

Exposure to depleted uranium does not alter the co expression of HER 2/neu and p53 in breast cancer patients

... and HER-2/neu markers does not differ from simi- lar cancer samples in areas that have not been exposed to depleted uranium, though, the greater immunoex- pression of ... See full document

8

Association between HER-2/neu over-expression and clinico-pathologic parameters of breast cancer in northern Malaysia

... An inverse association between ER and PR with HER-2/ neu has been observed by others [10, 13, 14]. In our study, ER negativity was more strongly associated with HER-2/neu ... See full document

5

C myc, not HER 2/neu, can predict recurrence and mortality of patients with node negative breast cancer

... conferred by adjuvant chemotherapy or endocrine therapy was examined in randomized studies [2,3,8,9,35–38]. Because adjuvant therapies may positively impact on outcome in only around 15%, the costs of these ... See full document

7

3, 39-diindolylmethane Enhances the Effectiveness of Herceptin against HER-2/Neu-Expressing Breast Cancer Cells

... Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, United States of America, 2 Division of Hematology/ Oncology, Karmanos Cancer Institute, Wayne State ... See full document

11

Clinical course of HER-2 positive breast cancer patients

... proteina her-2 (humani epidermalni receptor 2 za rastni faktor) in pomnožitev gena ...Protein her-2 je čezmerno izražen oziroma gen HER2 je pomnožen pri okoli 20 % bolnic z rakom ... See full document

5

Update on HER 2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition

... for breast cancer, and they generally correspond to differentiation antigens or over- expressed normal ...for breast cancer [2], but most of them are expressed on only a small ... See full document

5

Triplex formation inhibits HER 2/neu transcription in vitro

... Triplex-forming oligonucleotides (TFOs) have been shown to bind to target DNA sequences in several human gene promoters such as the c-myc oncogene, the epidermal growth factor receptor, and the dihydrofolate reductase ... See full document

8